Literature DB >> 8516365

D1 dopamine receptors in the nucleus accumbens modulate cocaine self-administration in the rat.

R Maldonado1, P Robledo, A J Chover, S B Caine, G F Koob.   

Abstract

Previous work using systemic injections of dopamine receptor antagonists has established that dopamine D1 receptors may have a role in cocaine self-administration. The purpose of the present study was to test the hypothesis that these effects were mediated by dopamine D1 receptors in the region of the nucleus accumbens. Animals were trained to perform operant responses to self-administer cocaine via an IV catheter on a fixed-ratio 5 (FR 5) schedule of reinforcement. SCH23390, a selective D1 dopamine antagonist, significantly increased the self-administration of cocaine when injected into the nucleus accumbens. This increase in self-administration is thought to reflect decreases in the magnitude of the reinforcer, similar to the increase observed when the dose of cocaine is reduced. Similar doses of SCH23390 injected into the posterior caudate nucleus failed to alter cocaine self-administration. These data suggest that D1 receptors in the nucleus accumbens are important for the reinforcing properties of cocaine.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8516365     DOI: 10.1016/0091-3057(93)90112-7

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  39 in total

1.  Firing rate of nucleus accumbens neurons is dopamine-dependent and reflects the timing of cocaine-seeking behavior in rats on a progressive ratio schedule of reinforcement.

Authors:  S M Nicola; S A Deadwyler
Journal:  J Neurosci       Date:  2000-07-15       Impact factor: 6.167

2.  Blockade of D1 dopamine receptors in the ventral tegmental area decreases cocaine reward: possible role for dendritically released dopamine.

Authors:  R Ranaldi; R A Wise
Journal:  J Neurosci       Date:  2001-08-01       Impact factor: 6.167

Review 3.  The nucleus accumbens as part of a basal ganglia action selection circuit.

Authors:  Saleem M Nicola
Journal:  Psychopharmacology (Berl)       Date:  2006-09-16       Impact factor: 4.530

4.  Role of oxytocin in the ventral tegmental area in social reinforcement.

Authors:  Johnathan M Borland; Kymberly N Grantham; Lauren M Aiani; Kyle J Frantz; H Elliott Albers
Journal:  Psychoneuroendocrinology       Date:  2018-05-21       Impact factor: 4.905

Review 5.  Basal ganglia circuit loops, dopamine and motivation: A review and enquiry.

Authors:  Satoshi Ikemoto; Chen Yang; Aaron Tan
Journal:  Behav Brain Res       Date:  2015-04-20       Impact factor: 3.332

6.  Roles for nigrostriatal--not just mesocorticolimbic--dopamine in reward and addiction.

Authors:  Roy A Wise
Journal:  Trends Neurosci       Date:  2009-09-14       Impact factor: 13.837

7.  Distinct contributions of dopamine in the dorsolateral striatum and nucleus accumbens shell to the reinforcing properties of cocaine.

Authors:  Maartje M J Veeneman; Mark H Broekhoven; Ruth Damsteegt; Louk J M J Vanderschuren
Journal:  Neuropsychopharmacology       Date:  2011-09-14       Impact factor: 7.853

8.  Individual variation in the motivational and neurobiological effects of an opioid cue.

Authors:  Lindsay M Yager; Kyle K Pitchers; Shelly B Flagel; Terry E Robinson
Journal:  Neuropsychopharmacology       Date:  2015-03-13       Impact factor: 7.853

9.  Cross-Generational trans Fat Consumption Favors Self-Administration of Amphetamine and Changes Molecular Expressions of BDNF, DAT, and D1/D2 Receptors in the Cortex and Hippocampus of Rats.

Authors:  Fábio Teixeira Kuhn; Verônica Tironi Dias; Karine Roversi; Luciana Taschetto Vey; Daniele Leão de Freitas; Camila Simonetti Pase; Katiane Roversi; Juliana Cristina Veit; Tatiana Emanuelli; Marilise Escobar Bürger
Journal:  Neurotox Res       Date:  2015-07-19       Impact factor: 3.911

Review 10.  The Molecular Basis of Drug Addiction: Linking Epigenetic to Synaptic and Circuit Mechanisms.

Authors:  Eric J Nestler; Christian Lüscher
Journal:  Neuron       Date:  2019-04-03       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.